In the quality control of active pharmaceutical ingredients (APIs) and excipients, hyperspectral fingerprinting serves as a robust analytical technique for high-throughput authenticity verification and purity screening. APIs and excipients derived from diverse synthetic routes or distinct manufacturing batches present diagnostic absorption deviations across the visible to near-infrared (VNIR, 400–1000 nm) and short-wave infrared (SWIR, 1000–2500 nm) regions due to polymorphic variations, particle size distributions, and trace impurity profiles. Utilizing a high-performance laboratory hyperspectral imaging system enables the simultaneous acquisition of spatial coordinates and contiguous spectral channels. Coupling these hyperspectral hypercubes with chemometric classifiers supports real-time, second-level material classification. The HG-HyperLab laboratory hyperspectral imager, developed by Hagorun Technology Limited, features high spectral resolution and stable line-scan push-broom imaging architecture, gaining wide recognition and industrial adoption for rapid raw material verification. To detect excipient adulteration or foreign matter contamination within bulk drug materials, hyperspectral imaging offers critical analytical capabilities. Utilizing image texture analytics across diagnostic bands and principal component clustering algorithms isolates trace adulterated zones indistinguishable to the human eye, outputting intuitive false-color distribution profiles of spatial anomalies. Testing protocols driven by the HG-HyperLab system eliminate complex chemical sample pre-treatments and reduce single-scan execution intervals, making it ideal for the rapid screening of incoming raw materials prior to warehouse storage. For polymorphic pharmaceuticals exhibiting structural differences (such as Amoxicillin, Famotidine, etc.), hyperspectral imaging coupled with deep learning architectures achieves rapid polymorph classification and quantitative characterization of single granules or bulk powder samples with high classification accuracy. This non-destructive methodology has been integrated into incoming material inspection pipelines by several pharmaceutical manufacturers to enhance quality control throughput.

The manufacturing of solid dosage forms progresses through multiple unit operations, including powder blending, granulation, tableting, and film coating, where inline quality monitoring represents a critical requirement for ensuring batch-to-batch consistency. Hyperspectral imaging serves as a core tool for Process Analytical Technology (PAT), finding extensive applications in mapping blending uniformity, core tablet constituent distribution, and coating thickness profiles. During laboratory formulation development, the HG-HyperLab hyperspectral imaging system tracks blending kinematics by capturing sequential hypercubes of powder matrices at distinct time intervals, establishing blending homogeneity models to isolate the precise mixing endpoint. Within finished tablet inspection workflows, hyperspectral configurations map the spatial distribution uniformity of active ingredients, film coat cosmetic anomalies, and microscopic foreign matter contamination. The high spatial resolution of the HG-HyperLab system captures cross-sectional profiles of split tablets, mapping the precise morphology of APIs and auxiliary excipients to guide formulation optimization. For modified-release and controlled-release matrices, hyperspectral mapping tracks the structural integrity of localized drug-releasing layers, serving as an indicator for predicting in vitro dissolution kinetics. Leading pharmaceutical enterprises have incorporated hyperspectral-driven tablet uniformity monitoring protocols into their primary quality assurance infrastructure. For traditional medicine formulations and solid herbal extracts, hyperspectral imaging supports rapid species identification, botanical classification, and multi-constituent quality screening. Bundled with the advanced analytical software suite of the HG-HyperLab platform, users can deploy custom chemometric models to transform raw hypercube acquisitions into automated compliance reports. This integrated solution is highly optimized for hospital preparation rooms and rapid quality control deployment across traditional medicine extraction facilities.

The material integrity of primary packaging structures regulates long-term formulation stability and patient safety metrics. Hyperspectral imaging systems evaluate sealing border integrity across aluminum-plastic blister packages, detect surface anomalies on elastomeric vial stoppers, and verify security features on labels. Incorporating premium spatial resolution, the HG-HyperLab system isolates micro-scale packaging pinholes and foreign object inclusions, providing a non-destructive method for screening internal contamination through transparent or semi-translucent barriers. Throughout logistics networks and market regulatory enforcement, hyperspectral imaging provides field inspectors with an advanced tool for the rapid field screening of counterfeit or substandard drugs. Utilizing laboratory-grade hyperspectral platforms enables non-destructive scanning of suspicious product lots, achieving rapid initial screening through cross-correlation of spectral libraries. The HG-HyperLab platform utilizes a modular hardware design optimized for deployment across National Institutes for Drug Control laboratories and port-of-entry inspection facilities. This architecture allows users to establish custom reference databases of authentic formulations, supporting regional spectral registry sharing networks to maximize target-driven sampling efficiency. For temperature-sensitive biologicals and vaccine formulations undergoing cold chain transport, hyperspectral configurations can evaluate cold chain exposure histories by monitoring spectral signature changes of surface chemical indicators attached to the outer packaging. This non-contact inspection provides an innovative technical dimension for lifecycle quality traceability, merging with enterprise information management networks to build comprehensive spectral reference archives across pharmaceutical distribution chains.

Interested in Advancing Hyperspectral Imaging Applications?

Our engineering group delivers advanced technical consulting and integrated solutions

Hagorun Technology Limited  |  Focus · Dedication · Exploration · Vision